Jeoffrey Bispham
Overview
Explore the profile of Jeoffrey Bispham including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laffel L, Sherr J, Liu J, Wolf W, Bispham J, Chapman K, et al.
Diabetes Care
. 2024 Dec;
48(2):273-278.
PMID: 39699995
Objective: We captured continuous glucose monitoring (CGM) metrics from a large online survey of adults with type 1 diabetes to determine how glycemic outcomes varied by insulin delivery form. Research...
2.
Sherr J, Laffel L, Liu J, Wolf W, Bispham J, Chapman K, et al.
Diabetes Care
. 2024 Jan;
47(6):941-947.
PMID: 38295397
Objective: To determine how diabetes technologies, including continuous glucose monitoring (CGM) and automated insulin delivery (AID) systems, impact glycemic metrics, prevalence of severe hypoglycemic events (SHEs), and impaired awareness of...
3.
Holt E, Nguyen H, Bispham J, Liu J, Chapman K, Grady M
Clin Diabetes
. 2024 Jan;
42(1):104-115.
PMID: 38230340
Manufacturers continue to improve performance and usability of continuous glucose monitoring (CGM) systems. As CGM becomes a standard of care, especially for people on insulin therapy, it is important to...
4.
Hughes A, Chapman K, Nguyen H, Liu J, Bispham J, Winget M, et al.
Clin Diabetes
. 2023 Jul;
41(3):399-410.
PMID: 37456102
Severe hypoglycemia (SH) is the most frequent and potentially serious complication affecting individuals with type 1 diabetes and can have major clinical and psychosocial consequences. Glucagon is the only approved...
5.
Liu J, Poon J, Bispham J, Perez-Nieves M, Hughes A, Chapman K, et al.
J Patient Rep Outcomes
. 2023 May;
7(1):43.
PMID: 37160500
Background: Fear of Hypoglycemia (FoH) in people with diabetes has a significant impact on their quality of life, psychological well-being, and self-management of disease. There are a few questionnaires assessing...
6.
Hughes A, Chapman K, Bispham J, Dimsits J, Weinzimer S, Wolf W, et al.
J Clin Transl Endocrinol
. 2023 Jan;
30:100310.
PMID: 36620758
Introduction: This study characterized the emotional impact of severe hypoglycemia, views of glucagon, and barriers to glucagon use from the perspective of adults with type 1 diabetes (T1D). Methods: Participants...
7.
Chapman K, Hughes A, Bispham J, Leon C, Nguyen H, Wolf W
Curr Diab Rep
. 2022 Apr;
22(4):199-201.
PMID: 35377111
No abstract available.
8.
Emergency Glucagon: a Focused Review of Psychosocial Experiences of Rescue Drugs for Type 1 Diabetes
Chapman K, Hughes A, Bispham J, Leon C, Nguyen H, Wolf W
Curr Diab Rep
. 2022 Feb;
22(4):189-197.
PMID: 35171447
Purpose Of Review: The purpose of this paper is to describe rescue glucagon types, safety, efficacy, and preferences, as well as to review articles regarding emergency glucagon usage, severe hypoglycemia,...
9.
Hughes A, Bispham J, Fan L, Nieves-Perez M, McAuliffe-Fogarty A
J Patient Exp
. 2021 Jan;
7(6):911-914.
PMID: 33457519
Limited research exists regarding the burdens associated with type 1 diabetes (T1D). The study's objective was to understand the impact of T1D from people with T1D and caregivers of minors...
10.
Piras de Oliveira C, Mitchell B, Fan L, Garey C, Liao B, Bispham J, et al.
Curr Med Res Opin
. 2020 Oct;
37(1):45-51.
PMID: 33108218
Background: Half-unit pens offer the ability to dose insulin more precisely. Information about half-unit pen use and evidence of their benefits and drawbacks is limited. This study aims to characterize...